Pharma Now - Empowering Pharma Leadership’s Post

Do all digital therapeutics companies have to take the pharma partnership route to guarantee commercial success? What are pharma players looking for in a DTx partner? And have either partners worked out what the most robust business model is for commercialising DTx together with drugs? These are just a few questions I'll be asking my panel of esteemed speakers (comprising Marko Kuisma Shahram Sharif Gregoire Guillet Ashutosh Malhotra) at LSX World Congress next Monday, April 29th. We'll be deconstructing past and existing partnerships our panellists have had with DTx companies and pick out what works and what doesn't. Of course, it takes two to tango so this is opportunity for DTx companies to share with the panel their experience with pharma. If you can't make the panel but attending the meeting, do come and connect/re-connect with me over coffee and several pastries (hopefully they will be proper man-sized buns and not made for Lilliputians). #LSXWorld https://lnkd.in/dBFexViz #digitaltherapeutics #digitalanddrugs #digitalhealth #pharmapartnerships #strategy #healthtech Informa Connect

🧬ATMPs are highly innovative technologies developed as a result of a long, complex and often difficult research, development and market access process. 👩🔬As these transformative therapies come to the European market in greater numbers, and as their importance to the competitiveness of the Single Market is becoming increasingly apparent, we put together a short but comprehensive guide to the ATMP lifecycle, zeroing in on the complex processes and most significant hurdles developers must navigate at each stage of the cycle. 🔬Click here to find out what it takes to bring ATMPs to the lives of European patients: https://lnkd.in/eKhrXqwF #ATMPs #cellandgenetherapy #orphandrug #innovation

1. Build foundations and have a) Ontologies and b) data available - accessible, understandable, usable. 2. Create Knowledge Graphs connecting the data with appropriate semantics - based on a value use case. 3. Search & Find by Graph Browsing and using LLMs.

We had the opportunity to sit down with Farzad Abdi-Dezfuli from Sarsia during #NLSdays, discussing their investment focus in two key areas: Life Sciences and Technology, Energy, and Sustainability.  In Life Sciences, Sarsia is driving innovation by addressing unmet medical needs, turning cutting-edge lab results into life-saving treatments. In Technology, Energy, and Sustainability, they're investing in solutions that accelerate the green transition and build sustainable companies for a better future.  Watch the full interview to learn more about their vision and impact!

It's humbling to see the impact of the work we began in December 2017, and I also want to express my gratitude to the ISoP Board of Directors for recognizing the Mosun Digital Twins work as an outstanding research manuscript. This serves as a valuable reminder that the novel efforts we undertake today take time, perhaps many years, to mature and make a meaningful difference in the community. https://lnkd.in/gb_u_xC5

🏃♂️ Ready to hit the ground running at #DPHARM2024? Be sure to connect with Jeffrey Golden and the rest of the Science 37 team while you're there. We have a new digital experience to share at our booth, a great group of individuals onsite, and so much more planned. See you next week! DPHARM: Disruptive Innovations to Modernize Clinical Research #clinicalresearch #clinicaltrials #clinicalstudies

Check this out! The RaDAR PPI just launched the first episode on how this #procurement of #innovation is aiming to tackle the #AMR challenge!

CPhI Milan 2024: the very first full work day! 🌟 It feels awesome to be in Milan for the CPhI 2024 event these days, and the vibes around are just magnificent! There has been so much exchanged, from fruitful engagement with industry experts, associates and the latest technology, the day has been flooded with a lot of ideas and opportunities. 🚀 Safety and effectiveness within the pharma industries are the two concerns most important to Artis Biotech and today, I was fortunate enough to meet with such people, interact with state-of-the-art approaches, and get acquainted with innovations that all along our three core values of Artis Biotech Authenticity, Speed, and Synergy! 💡 In the next two days, please let me indulge in learning, expanding my network, and figuring out how to take advantage of the opportunities! 🌍 Let's catch up on the third day (10th OCT) if you are here... 👍 #CPHIMilan #PharmaIndustry #Innovation #ArtisBiotech #OxyproLabs #Networking #Impurities #GlobalHealth #Collaboration

💡 Want to learn more about AMR? Check out RaDAR's new animated series🎬 It explains the #AMR challenge and how #innovation through #PPI is key to tackling it. 🌍